Healthcare research from Johnson & Johnson, page 27
A filtered view. Show the full list.
Refine
Listings
-
ArticleNature communications
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleSchizophrenia (Heidelberg, Germany)
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Research dataAdded
-
ArticleNature chemistry
Accessing sulfonamides via formal SO2 insertion into C-N bonds
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleNature
Strategic atom replacement enables regiocontrol in pyrazole alkylation
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Other scienceAdded
-
ArticleNature biotechnology
Folding-mediated secretion of pure bispecific antibodies
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
Clinical trial reportNature medicine
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleNature medicine
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
Clinical trial reportNature medicine
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleScientific reports
A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleScientific reports
Prediction of treatment-resistant depression using the 23andMe survey data
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleNPJ digital medicine
Standardized patient profile review using large language models for case adjudication in observational research
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleNPJ digital medicine
A systematic review of digital and imaging technologies for measuring fatigue in immune mediated inflammatory diseases
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleNPJ digital medicine
Unlocking efficiency in real-world collaborative studies: a multi-site international study with one-shot lossless GLMM algorithm
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Research dataAdded
-
ArticleCommunications biology
Unveiling inverted D genes and D-D fusions in human antibody repertoires unlocks novel antibody diversity
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleCommunications biology
Genetic background and oncogenic driver determines the genomic evolution and transcriptomics of mammary tumor metastasis
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
Clinical trial reportGastroenterology
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewGastroenterology
Artificial Intelligence-Enabled Clinical Trials in Inflammatory Bowel Disease: Automating and Enhancing Disease Assessment and Study Management
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
Clinical trial reportAmerican journal of perinatology
Design of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportAmerican journal of perinatology
Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Research dataAdded
-
Clinical trial reportNEJM evidence
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Case reportThe New England journal of medicine
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportThe New England journal of medicine
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded